Skip Navigation
Skip to contents




17 results

Abuse Liability of Baclofen

Praharaj S

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):126-127.
  • doi: 10.9758/cpn.2018.16.1.126
No abstract available.
Combined Use of Duloxetine and Olanzapine in the Treatment of Urologic Chronic Pelvic Pain Syndromes Refractory to Conventional Treatment: A Case Report

Bi B, Shan L, Zhou D

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):122-125.
  • doi: 10.9758/cpn.2018.16.1.122
Patients with urologic chronic pelvic pain syndromes (UCPPS) report interstitial cystitis/bladder pain syndrome and/or chronic prostatitis/chronic pelvic pain syndrome. The pathogenesis of these syndromes remains unclear and there is currently...
Risperidone Related Raynaud's Phenomenon: An Adolescent Case

Güneş S, Ekinci O, Teke H, Yıldırım V

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):118-121.
  • doi: 10.9758/cpn.2018.16.1.118
Raynaud's phenomenon is a recurrent vasospastic condition with reducing in peripheral blood flow due to cold, or emotional stress. White, blue and red discolorations occur during the attacks. Serotonin reuptake...
Polydipsia as a Precursor of Manic Episode in Bipolar Affective Disorder Patients with Alcohol Use Disorder

Ceylan ME, Ãœnsalver , Evrensel A

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):114-117.
  • doi: 10.9758/cpn.2018.16.1.114
Bipolar affective disorder (BD) diagnosis and initiation of appropriate treatment are often delayed, and this is associated with poorer outcomes, such as rapid cycling or cognitive decline. Therefore, identifying certain...
Limbic Encephalitis Manifesting as Selective Amnesia and Seizure-like Activity: A Case Report

Kim SY, Um YH, Lim SC, Jeong JH

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):109-113.
  • doi: 10.9758/cpn.2018.16.1.109
Limbic encephalitis (LE) is characterized by short-term memory loss, disorientation, agitation, seizures, and histopathological evidence of medial temporal lobe inflammation. Leucine-rich, glioma inactivated 1 (LGI-1) is an auto-antigen associated with...
Depression and Mania Induce Pro-inflammatory Activation of Macrophages Following Application of Serum from Individuals with Bipolar Disorder

Ferrari P, Parisi MM, Colombo R, Becker M, Fries G, Ascoli BM, Géa LP, Kauer-Sant’anna M, Kapczinski F, Klamt F, Guma FT, Rosa AR, Barbé-Tuana FM

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):103-108.
  • doi: 10.9758/cpn.2018.16.1.103
OBJECTIVE: Evidence has suggested that immune imbalance is involved with bipolar disorder (BD); however, its precise mechanism is poorly understood. This study investigated whether biochemical changes in the serum from...
The Association between Suicide Attempts and Toxoplasma gondii Infection

Bak J, Shim SH, Kwon YJ, Lee HY, Kim JS, Yoon H, Lee YJ

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):95-102.
  • doi: 10.9758/cpn.2018.16.1.95
OBJECTIVE: Chronic ‘latent’ infection by Toxoplasma gondii is common and most of the hosts have minimal symptoms or they are even asymptomatic. However, there are possible mechanisms by which T....
The Diagnostic Value of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Drug Naïve, First Episode, Non-Smoker Generalized Anxiety Disorder Patients

Fındıklı E, Camkurt MA, İzci F, Karaaslan , Fındıklı HA, Sümer P, Kurutaş E

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):88-94.
  • doi: 10.9758/cpn.2018.16.1.88
OBJECTIVE: Generalized anxiety disorder (GAD) is a common anxiety disorder. Although lots of research done to reveal neurobiological basis of GAD, it is still unclear. Diagnosis of GAD depends on...
Korean Medication Algorithm for Depressive Disorders 2017: Third Revision

Seo JS, Bahk WM, Wang HR, Woo YS, Park YM, Jeong JH, Kim W, Shim SH, Lee JG, Jon DI, Min KJ

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):67-87.
  • doi: 10.9758/cpn.2018.16.1.67
OBJECTIVE: In 2002, the Korean Society for Affective Disorders developed the guidelines for the treatment of major depressive disorder (MDD), and revised it in 2006 and 2012. The third revision...
The Effects of Repetitive Transcranial Magnetic Stimulation at Dorsolateral Prefrontal Cortex in the Treatment of Migraine Comorbid with Depression: A Retrospective Open Study

Kumar S, Singh S, Kumar N, Verma R

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):62-66.
  • doi: 10.9758/cpn.2018.16.1.62
OBJECTIVE: The literature on managing migraine non-responsive to pharmacological approaches and that co-occurring with depression is scanty. The comorbid condition predicts a poorer prognosis for migraine as well as depression....
Efficacy and Safety Profile of Risperidone Long-acting Injection in Adolescents in a Real-life Setting

Ardic UA, Küçükköse M, Inci SB, Ercan ES

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):57-61.
  • doi: 10.9758/cpn.2018.16.1.57
OBJECTIVE: Risperidone long-acting injection (RLAI) was shown to be an alternative option in adult patients, but there is not available data in child and adolescents about this medication. The aim...
Hippocampal Subfields Volume Reduction in High Schoolers with Previous Verbal Abuse Experiences

Lee SW, Yoo JH, Kim KW, Kim D, Park H, Choi J, Teicher MH, Jeong B

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):46-56.
  • doi: 10.9758/cpn.2018.16.1.46
OBJECTIVE: Reduced hippocampal volume and alterations in white matter tracts have been frequently reported in adults having the history of emotional maltreatment. We investigated whether these structural change occur in...
Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs

Dogan HO, Ersan EE, Aydin H, Erdoğan S, Erşan S, Alişik M, Bakir S, Erel O, Koç D

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):39-45.
  • doi: 10.9758/cpn.2018.16.1.39
OBJECTIVE: Schizophrenia is a severe, debilitating mental disorder characterized by behavioral abnormalities. Although several studies have investigated the role of oxidative stress and the effects of antipsychotic drugs on oxidative...
Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics

Pavăl D, Nemeş B, Rusu RL, Dronca E

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):32-38.
  • doi: 10.9758/cpn.2018.16.1.32
OBJECTIVE: Recent studies suggest a possible involvement of low paraoxonase 1 (PON1) enzyme activities in the association between schizophrenia, treatment with atypical antipsychotics and increased cardiovascular (CVD) risk. In the...
From Neurons to Social Beings: Short Review of the Mirror Neuron System Research and Its Socio-Psychological and Psychiatric Implications

Jeon H, Lee SH

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):18-31.
  • doi: 10.9758/cpn.2018.16.1.18
The mirror neuron system (MNS) is a brain network activated when we move our body parts and when we observe the actions of other agent. Since the mirror neuron's discovery...
Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies

Tripathi A, Kar SK, Shukla R

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):7-17.
  • doi: 10.9758/cpn.2018.16.1.7
Cognitive deficits are one of the core symptoms of schizophrenia that evolve during the course of schizophrenia, after being originated even before the onset of illness. Existing pharmacological and biological...
The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants

Serretti A

  • Clin Psychopharmacol Neurosci.
  • 2018 Feb;16(1):1-6.
  • doi: 10.9758/cpn.2018.16.1.1
Precision medicine is a concept which is recently gaining momentum in all branches of medicine. In particular in psychiatry it is greatly needed given the huge societal costs of psychiatric...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: